Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04361240 · ClinicalTrials.gov registry record
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 172
- Enrollment target
NCT04361240 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 172 participants.
The verdict
NCT04361240 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 172 participants
- Enrollment target
Study Summary
This is a companion study to the "Pragmatic Randomized Trial of Proton vs Photon Therapy for Patients with non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RadComp) Consortium Trial" (NCT02603341). The investigators will collect cardiovascular (CV) biomarkers and echocardiograms prior to, during, and for up to 1 year following radiation for a subset of patients enrolled on RadComp and to evaluate the impact of proton vs photon radiation therapy (RT) on CV function and structure.
Interventions
- RADIATION Proton vs Photon Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2025-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04361240
The ClinicalTrials.gov registry entry for NCT04361240 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proton vs Photon Radiation is the first listed.
NCT04361240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04361240 about?
NCT04361240 is a clinical study titled "Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study". This is a companion study to the "Pragmatic Randomized Trial of Proton vs Photon Therapy for Patients with non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RadComp) Consortium Trial" (NCT02603341). The investigators will collect cardiova...
What is the current status of trial NCT04361240?
This trial is currently completed. The enrollment target is 172 participants. The study started on 2020-08-01. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT04361240?
The interventions under investigation include: Proton vs Photon Radiation (RADIATION).
Who is sponsoring clinical trial NCT04361240?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.